Clinical Trial Update: Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) [NA]

View source ↗

Summary

Update on the PECANS study, a pan-European trial evaluating antipsychotic-naive patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University of Copenhagen | Conditions: Schizophrenia | NA | Status: COMPLETED